Free Trial

Etzer Darout Analyst Performance

Analyst at Barclays

Etzer Darout is a stock analyst at Barclays focused in the medical sector, covering 35 publicly traded companies. Over the past year, Etzer Darout has issued 133 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Etzer Darout's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Etzer Darout's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
152 Last 6 Years
Buy Recommendations
81.88% 122 Buy Ratings
Companies Covered
35 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy2.0%3 ratings
Buy79.9%119 ratings
Hold12.1%18 ratings
Sell6.0%9 ratings

Out of 149 total stock ratings issued by Etzer Darout at Barclays, the majority (79.9%) have been Buy recommendations, followed by 12.1% Hold, 6.0% Sell, and 2.0% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
35 companies

Etzer Darout, an analyst at Barclays, currently covers 35 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
34 companies
97.1%
Manufacturing
1 company
2.9%

Etzer Darout of Barclays specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
27 companies
77.1%
MED - DRUGS
5 companies
14.3%
BIOTECHNOLOGY
1 company
2.9%
MED PRODUCTS
1 company
2.9%
PHARMACEUTICAL PREPARATIONS
1 company
2.9%

Etzer Darout's Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Reiterated Rating$123.24$124.00Equal Weight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Downgrade$123.35Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/27/2026Boost Price Target$237.41$253.00Overweight
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
5/20/2026Boost Price Target$12.07$27.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
5/13/2026Boost Price Target$9.57$20.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/13/2026Boost Price Target$65.58$75.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
5/8/2026Boost Price Target$46.45$55.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
5/8/2026Boost Price Target$33.05$48.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/6/2026Boost Price Target$212.26$234.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
5/1/2026Boost Price Target$19.86$37.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/27/2026Boost Price Target$82.33$160.00Overweight
TRAX
First Tracks Biotherapeutics
4/22/2026Initiated Coverage$17.00$40.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
4/22/2026Lower Price Target$51.82$63.00Overweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
4/20/2026Boost Price Target$3.46$6.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
4/20/2026Boost Price Target$203.42$225.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
4/20/2026Boost Price Target$44.89$45.00Equal Weight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
4/20/2026Downgrade$15.82$14.00Underweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
4/20/2026Upgrade$34.55$45.00Overweight
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/8/2026Boost Price Target$14.23$21.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/7/2026Boost Price Target$58.94$78.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/30/2026Reiterated Rating$52.87$53.00Equal Weight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/27/2026Downgrade$52.88Hold
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
3/24/2026Boost Price Target$115.07$148.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
3/19/2026Boost Price Target$102.06$119.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/19/2026Boost Price Target$4.86$16.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
3/13/2026Boost Price Target$39.79$50.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2026Lower Price Target$91.57$128.00Outperform
MacroGenics, Inc. stock logo
MGNX
MacroGenics
3/10/2026Boost Price Target$2.93$4.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
3/9/2026Reiterated Rating$185.40$224.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/4/2026Boost Price Target$56.22$79.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/4/2026Boost Price Target$45.78$70.00Outperform
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/3/2026Boost Price Target$44.31$53.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/27/2026Initiated Coverage$188.97$224.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
2/26/2026Boost Price Target$2.75$7.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
2/26/2026Boost Price Target$13.37$27.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/26/2026Boost Price Target$86.70$113.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
2/25/2026Boost Price Target$4.27$11.00Overweight
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/24/2026Boost Price Target$9.50$30.00Overweight
Incyte Corporation stock logo
INCY
Incyte
2/18/2026Boost Price Target$101.16$117.00Overweight
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/17/2026Set Price Target$7.47$26.00
Is SpaceX really worth 1.78 Trillion? (Ad)

With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analyst Lance Ippolito says the real opportunity is elsewhere. He's identified 5 dirt-cheap stocks at the forefront of this mega-IPO, including a space ticker that Goldman Sachs, BlackRock, and Morgan Stanley are all buying, a rare resource miner Elon's entire empire depends on, and the chip supplier Starlink satellites can't function without. Access his free SpaceX Investing Blackbook before IPO day arrives.tc pixel

Get the free SpaceX Investing Blackbook and see all 5 names
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/4/2026Reiterated Rating$7.68$24.00Overweight
Incyte Corporation stock logo
INCY
Incyte
2/4/2026Boost Price Target$100.92$116.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
2/4/2026Boost Price Target$42.59$44.00Equal Weight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
2/4/2026Boost Price Target$6.07$10.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/21/2026Downgrade$57.61$58.00Equal Weight
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
1/20/2026Boost Price Target$21.43$28.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
1/20/2026Boost Price Target$5.39$8.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/20/2026Boost Price Target$45.68$78.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
12/17/2025Boost Price Target$16.55$26.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
12/17/2025Boost Price Target$44.32$52.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
12/17/2025Boost Price Target$91.54$108.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
12/17/2025Lower Price Target$14.65$29.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
12/17/2025Boost Price Target$2.25$10.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
12/17/2025Lower Price Target$2.26$5.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
12/17/2025Boost Price Target$11.90$18.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
12/17/2025Lower Price Target$45.03$55.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
12/17/2025Set Price Target$17.23$18.00
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
12/17/2025Upgrade$17.23$18.00Equal Weight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
12/17/2025Boost Price Target$26.61$24.00Underweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
12/17/2025Boost Price Target$2.82$10.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
12/9/2025Boost Price Target$40.23$56.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/9/2025Boost Price Target$94.30$119.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/25/2025Boost Price Target$28.04$36.00Overweight
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
11/24/2025Reiterated Rating$11.17$28.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
11/24/2025Boost Price Target$2.24$9.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
11/24/2025Boost Price Target$18.44$35.00Overweight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
11/17/2025Set Price Target$108.00$152.00
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/17/2025Boost Price Target$36.58$45.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/14/2025Reiterated Rating$37.47$50.00Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/11/2025Boost Price Target$19.12$28.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/11/2025Lower Price Target$33.98$70.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
11/11/2025Lower Price Target$22.98$21.00Underweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
11/7/2025Lower Price Target$28.60$56.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
11/7/2025Boost Price Target$78.49$88.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
11/7/2025Boost Price Target$25.63$48.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
11/6/2025Boost Price Target$9.82$16.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
11/5/2025Boost Price Target$59.91$70.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$37.90$41.00Equal Weight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/4/2025Boost Price Target$14.03$27.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
10/29/2025Upgrade$14.25$23.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
10/29/2025Upgrade$14.25$23.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
10/22/2025Lower Price Target$7.61$14.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
10/21/2025Boost Price Target$20.03$16.00Underweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
10/21/2025Boost Price Target$3.74$6.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/21/2025Boost Price Target$33.67$58.00Overweight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Set Price Target$6.69$5.00Equal Weight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Initiated Coverage$41.60$61.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/13/2025Set Price Target$26.79$35.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/13/2025Initiated Coverage$24.49$48.00Overweight
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
10/13/2025Set Price Target$87.82$125.00Overweight
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
10/13/2025Initiated Coverage$6.93$16.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
10/13/2025Initiated Coverage$31.37$78.00Overweight
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/13/2025Initiated Coverage$93.77$142.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
10/13/2025Initiated Coverage$26.77$25.00Underweight
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/13/2025Initiated Coverage$95.63$142.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
10/13/2025Initiated Coverage$32.46$78.00Overweight
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
10/13/2025Initiated Coverage$7.11$16.00Overweight
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
10/13/2025Initiated Coverage$102.05$125.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/13/2025Initiated Coverage$25.50$48.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/13/2025Initiated Coverage$26.35$35.00Overweight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Initiated Coverage$6.69$61.00Overweight
Merus N.V. stock logo
MRUS
Merus
9/30/2025Reiterated Rating$93.67$97.00Equal Weight
Merus N.V. stock logo
MRUS
Merus
9/30/2025Downgrade$94.15$97.00Equal Weight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/24/2025Lower Price Target$33.75$44.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/22/2025Boost Price Target$3.16$10.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
9/17/2025Initiated Coverage$8.62$6.00Underweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
9/17/2025Initiated Coverage$1.47$3.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
9/17/2025Initiated Coverage$39.14$40.00Equal Weight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
9/17/2025Initiated Coverage$1.96$3.50Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
9/17/2025Initiated Coverage$7.64$16.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/17/2025Initiated Coverage$7.30$15.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/17/2025Initiated Coverage$18.12$13.00Underweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/17/2025Initiated Coverage$32.34$45.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/17/2025Initiated Coverage$58.59$72.00Overweight
Merus N.V. stock logo
MRUS
Merus
9/17/2025Initiated Coverage$66.90$112.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/17/2025Initiated Coverage$48.78$60.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
9/17/2025Initiated Coverage$23.41$47.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/17/2025Initiated Coverage$3.41$8.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
9/16/2025Upgrade$7.61Strong-Buy
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/16/2025Initiated Coverage$3.38$8.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
9/16/2025Upgrade$1.93Strong-Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
9/16/2025Upgrade$40.44Hold
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
9/16/2025Initiated Coverage$23.46$47.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/16/2025Initiated Coverage$48.12$60.00Overweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
9/16/2025Upgrade$1.53Strong-Buy
Merus N.V. stock logo
MRUS
Merus
9/16/2025Initiated Coverage$68.18$112.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/16/2025Initiated Coverage$59.22$72.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/16/2025Initiated Coverage$18.09$13.00Underweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/16/2025Initiated Coverage$31.95$45.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/16/2025Initiated Coverage$7.40$15.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
9/16/2025Upgrade$9.25Strong Sell
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
9/2/2025Boost Price Target$6.19$13.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
8/7/2025Lower Price Target$34.62$45.00Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
5/13/2025Lower Price Target$2.93$15.00Outperform
Verve Therapeutics, Inc. stock logo
VERV
Verve Therapeutics
4/15/2025Boost Price Target$5.07$24.00Buy
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
4/4/2025Lower Price Target$3.26$9.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/12/2025Set Price Target$8.51$20.00Outperform
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2025Boost Price Target$105.35$143.00Outperform
Arvinas, Inc. stock logo
ARVN
Arvinas
2/12/2025Reiterated Rating$18.88$82.00Outperform